Oramed Pharmaceuticals
ORMP
#8949
Rank
NZ$0.32 B
Marketcap
NZ$8.05
Share price
-0.22%
Change (1 day)
124.61%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2025 (TTM): NZ$98.84 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are NZ$2 Million. In 2024 the company made an earning of -NZ$26.38 Million a decrease over its 2023 earnings that were of NZ$12.47 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$98.84 M-474.74%
2024 -NZ$26.38 Million-311.47%
2023 NZ$12.47 M-119.45%
2022 -NZ$64.13 Million39.17%
2021 -NZ$46.08 Million73.93%
2020 -NZ$26.5 Million18.53%
2019 -NZ$22.35 Million-16.62%
2018 -NZ$26.81 Million38.32%
2017 -NZ$19.38 Million12.51%
2016 -NZ$17.23 Million25.01%
2015 -NZ$13.78 Million18.18%
2014 -NZ$11.66 Million39.72%
2013 -NZ$8.35 Million46.4%
2012 -NZ$5.7 Million128.32%
2011 -NZ$2.5 Million-51.47%
2010 -NZ$5.15 Million35.21%
2009 -NZ$3.81 Million
2007 -NZ$5.99 Million607.04%
2006 -NZ$0.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
NZ$43.78 B 42,800.59%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
NZ$13.40 B 13,035.88%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-NZ$0.94 Billion-1,020.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-NZ$0.13 Billion-217.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-NZ$48.26 Million-147.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel